Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESA
Circulation: Heart Failure, Ahead of Print. BACKGROUND:Common genetic variants are associated with risk for hypertrophic cardiomyopathy and dilated cardiomyopathy and
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Common genetic variants are associated with risk for hypertrophic cardiomyopathy and dilated cardiomyopathy and
Read moreBackground:Electronic health (e-Health), refers to technologies that can be utilized to enhance patient care as well as collect and share
Read moreTelemedicine and e-Health, Ahead of Print. Source link
Read moreAddress correspondence to: Kori S. Zachrison, MD, MSc, Department of Emergency Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Cardiac autoantibodies (cAAbs) are involved in the progression of adverse cardiac remodeling in heart
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:There is a paucity of data regarding epidemiology, temporal trends, and outcomes of patients
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Selecting high-risk patients with heart failure with potentially modifiable cardiovascular events is a priority.
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Patients with heart failure are vulnerable to the SARS-CoV-2 infection. However, limited evidence exists
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Heart failure is a prevailing diagnosis of hospitalization and readmission within 6 months, and
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and has few treatments.
Read more